Elissa J. Schwartz
CIK: 0001827177
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
GALT
GALECTIN THERAPEUTICS INC
Director
Discretionary Trading P&L
Holdings
About Schwartz Elissa J.
Schwartz Elissa J. (SEC CIK 0001827177) files insider reports with the SEC as Director of GALECTIN THERAPEUTICS INC (GALT).
Signal8 holds 2 ownership filings by Schwartz Elissa J., all Form 4s, filed between Jan 27, 2025 and Jan 21, 2026. Those filings report 2 transactions, from Jan 23, 2025 to Jan 16, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Schwartz Elissa J.'s filings is in NORCROSS, GA.
Recent filings by Schwartz Elissa J.
Other insiders filing for GALECTIN THERAPEUTICS INC (GALT)
- Uihlein Richard E, Director
- Jamil Khurram, Chief Medical Officer
- Shlevin Harold H., Director
- Brem Henry, Director
- ELDRED KARY, Director
- LEWIS JOEL, President and CEO